http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015031277-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e071d18fea054bf8d1420d483e78ed1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
filingDate 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_176d75ba2b53b9a59440f8df30e57933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f020c7faffb39965ee0188c84809fe21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ee12e497a61a5824dee37d35ebe4c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e1912a6ab2e3ab0f69c15b0f8ed655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbd09cac7126493d7988fce1cbef1262
publicationDate 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015031277-A2
titleOfInvention INSULIN RECEPTOR MODULATORS FROM STABILIZED POLYPEPTIDES, INSULIN ANALOGS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID POLYPEPTIDES AND METHODS OF PREPARATION AND USES THEREOF
abstract INSULIN RECEPTOR MODULATORS FROM STABILIZED POLYPEPTIDES, INSULIN ANALOGS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID POLYPEPTIDES AND PREPARATION METHODS AND USES THEREOF. Provided herein are stabilized (ALFA)-CT polypeptides comprising an alpha-helical segment and wherein the polypeptide is of Formula (I-1) or Formula (I-2): Rf-[XAA]s-XA1-XA2-XA3 -XA4-XA5-XA6-XA7-XA8-XA9-XA10-XA11-XA12-XA13-XA14-[XAA]t-Re(I-1)Rf-[XAA]s-XC1-XC2-XC3-XC4-XC5 -XC6-XC7-XC8-XC9-XC10-XC11-XC12-XC13-XC14-XC15-XC16-XC17-XC18-XC19-XC20-[XAA]t-Re(I-2) in which the Alpha-CT polypeptide is binds to the insulin receptor and wherein the Alpha-CT polypeptide includes at least one hairpin (i.e., two cross-linked amino acids) and/or at least one seam (i.e., three cross-linked amino acids). Further provided are insulin analogues which include stapled or stitched Alpha-CT polypeptides, pharmaceutical compositions thereof, methods of use, for example, methods of treating a diabetic condition or complications thereof.
priorityDate 2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID398006
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73940242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408017
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24954
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15208
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16337
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06213
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PVZ4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3643
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28516
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID420133

Total number of triples: 41.